CHIA-YU CHU2019-12-042019-12-0420121027-8117https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870860547&doi=10.1016%2fj.dsi.2012.11.001&partnerID=40&md5=06a11ee82f2d5ff1dd3d9ceab7683144https://scholars.lib.ntu.edu.tw/handle/123456789/434928[SDGs]SDG3chemokine; galectin; omalizumab; allergic asthma; atopic dermatitis; contact dermatitis; editorial; human; immunity; keratinocyte; psoriasis; skin; skin disease; Th17 celleditorial10.1016/j.dsi.2012.11.0012-s2.0-84870860547